Influenza vaccination during pregnancy and its usefulness to mothers and their young infants

Journal of Infection and Chemotherapy

Volumn 21, Issue 4, 2015, Pages 238-246

  Takeda, Satoshi ^a   Hisano, Michi ^b   Komano, Jun ^c   Yamamoto, Hiroyuki ^a   Sago, Haruhiko ^b   Yamaguchi, Koushi ^b  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Immunogenicity; Influenza; Pregnancy; Transplacental transfer; Vaccine; Vaccine safety

Indexed keywords

INFLUENZA VACCINE; MATERNAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ANTIBODY TITER; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; MEDICAL INFORMATION; NEWBORN; PANDEMIC INFLUENZA; PASSIVE IMMUNIZATION; PLACENTAL TRANSFER; PREGNANCY; PREGNANT WOMAN; REVIEW; BLOOD; IMMUNOLOGY; INFLUENZA, HUMAN; PREGNANCY COMPLICATIONS, INFECTIOUS; VACCINATION;

ANTIBODIES, VIRAL; FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; INFLUENZA VACCINES; INFLUENZA, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VACCINATION;

EID: 84930383718     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2015.01.015     Document Type: Review

References (92)

1. Shaw M.L., Palese P. Orthomyxoviridae. Fields virology 2013, 1151-1185. [Chapter 40]. 6th ed.
2. Wright P.F., Neumann G., Kawaoka Y. Orthomyxoviruses. Fields virology 2013, 1186-1243. [Chapter 41]. 6th ed.
3. Wilking A.N., Elliott E., Garcia M.N., Murray K.O., Munoz F.M. Central nervous system manifestations in pediatric patients with influenza A H1N1 infection during the 2009 pandemic. Pediatr Neurol 2014, 51:370-376.
4. Seasonal influenza (Flu). Information for specific groups. http://www.cdc.gov/flu/index.htm.
5. Centers for Disease Control and Prevention (CDC) Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009, 58:521-524.
6. Parren P.W., Burton D.R. The antiviral activity of antibodies invitro and invivo. Adv Immunol 2001, 77:195-262.
7. Grund S., Adams O., Wahlisch S., Schweiger B. Comparison of hemagglutination inhibition assay, an ELISA-based micro-neutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza A H1N1 2009 virus. JVirol Methods 2011, 171:369-373.
8. de Jong J.C., Palache A.M., Beyer W.E.P., Rimmelzwaan G.F., Boon A.C.M., Osterhous A.D.M.E. Haemagglutination-inhibiting antibody to influenza virus. Laboratory correlates of immunity to influenza - a reassessment 2003, 63-73. Developments in Biologicals, Karger, Bergen. F. Brown, L.R. Haaheim, J.M. Wood, G.C. Schild (Eds.).
9. Harris J.W. Influenza occurring in pregnant women: a statistical study of thirteen hundred and fifty cases. JAm Med Assoc 1919, 78:978-980.
10. DEATHS from Asian influenza, 1957 Areport by the Public Health Laboratory Service based on records from hospital and public health laboratories. Br Med J 1958, 1:915-919.
11. Freeman D.W., Barno A. Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol 1959, 78:1172-1175.
12. Greenberg M., Hacobziner H., Pakter H., Weisl G.A.G. Maternal mortality in the epidemic of Asian influenza, New York City, 1957. Am J Obstet Gynecol 1958, 76:897-902.
13. Irving W.L., James D.K., Stephenson T., Laing P., Jameson C., Oxford J.S., et al. Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG 2000, 107:1282-1289.
14. Naleway A.L., Smith W.J., Mullooly J.P. Delivering influenza vaccine to pregnant women. Epidemiol Rev 2006, 28:47-53.
15. Neuzil K.M., Reed G.W., Michel E.F., Simonsen L., Griffin M.R. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998, 148:1094-1102.
16. Dodds L., McNeil S.A., Fell D.B., Allen V.M., Coombs A., Scott J., et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ 2007, 176:463-468.
17. Hartert T.V., Neuzil K.M., Shintani A.K., Mitchel E.F., Snowden M.S., Wood L.B., et al. Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. Am J Obstet Gynecol 2003, 189:1705-1712.
18. Cox S., Posner S.F., McPheeters M., Jamieson D.J., Kourtis A.P., Meikle S. Hospitalizations with respiratory illness among pregnant women during influenza season. Obstet Gynecol 2006, 107:1315-1322.
19. Centers for Disease Control and Prevention (CDC) Use of influenza A (H1N1) 2009 monovalent vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009, 58:1-8.
20. Jamieson D.J., Honein M.A., Rasmussen S.A., Williams J.L., Swerdlow D.L., Biggerstaff M.S., et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009, 374:451-458.
21. Siston A.M., Rasmussen S.A., Honein M.A., Fry A.M., Seib K., Callaghan W.M., et al. Pandemic 2009 influenza A (H1N1) virus illness among pregnant women in the United States. JAm Med Assoc 2010, 303:1517-1525. Pandemic H1N1 Influenza in Pregnancy Working Group.
22. Håberg S.E., Trogstad L., Gunnes N., Wilcox A.J., Gjessing H.K., Samuelsen S.O., et al. Risk of fetal death after pandemic influenza virus infection or vaccination. NEngl J Med 2013, 368:333-340.
23. Saito S. Cytokine network at the feto-maternal interface. JReprod Immunol 2000, 47:87-103.
24. Tsuda H., Michimata T., Hayakawa S., Tanebe K., Sakai M., Fujimura M., et al. ATh2 chemokine, TARC, produced by trophoblasts and endometrial gland cells, regulates the infiltration of CCR4+ T lymphocytes into human decidua at early pregnancy. Am J Reprod Immunol 2002, 48:1-8.
25. Yamaguchi K., Hisano M., Isojima S., Irie S., Arata N., Watanabe N., et al. Relationship of Th1/Th2 cell balance with the immune response to influenza vaccine during pregnancy. JMed Virol 2009, 81:1923-1928.
26. Larson L., Mehta N., Paglia M.J., Bourjeily G., Ngan Kee W.D. Pulmonary disease in pregnancy. Medical disorders in obstetric practice 2010, 1-47. Wiley-Blackwell, MA, USA. 5th ed. M. De Swiet (Ed.).
27. Hsu J., Santesso N., Mustafa R., Brozek J., Chen Y.L., Hopkins J.P., et al. Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Ann Intern Med 2012, 156:512-524.
28. Tanaka T., Nakajima K., Murashima A., Garcia-Bournissen F., Koren G. Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breasfeeding women. CMAJ 2009, 181:55-58.
29. Greer L.G., Sheffield J.S., Rogers V.L., Roberts S.W., McIntire D.D., Wendel G.D. Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications. Obstet Gynecol 2010, 115:711-716.
30. Donner B., Niranjan V., Hoffmann G. Safety of oseltamivir in pregnancy: a review of preclinical and clinical data. Drug Saf 2010, 33:631-642.
31. Xie H.Y., Yasseen A.S., Xie R.H., Fell D.B., Sprague A.E., Liu N., et al. Infant outcomes among pregnant women who used oseltamivir for treatment of influenza during the H1N1 epidemic. Am J Obstet Gynecol 2013, 208:e1-e7.
32. Saito S., Minakami H., Nakai A., Unno N., Kubo T., Yoshimura Y. Outcomes of infants exposed to oseltamivir or zanamivir in utero during pandemic (H1N1) 2009. Am J Obstet Gynecol 2013, 209:e1-e9.
33. Dunstan H.J., Mill A.C., Stephens S., Yates L.M., Thomas S.H. Pregnancy outcome following maternal use of zanamivir or oseltamivir during the 2009 influenza A/H1N1 pandemic: a national prospective surveillance study. BJOG 2014, 121:901-906.
34. Wollenhaupt M., Chandrasekaran A., Tomianovic D. The safety of oseltamivir in pregnancy: an updated review of post-marketing data. Pharmacoepidemiol Drug Saf 2014, 23:1035-1042.
35. American College of Obstetricians and Gynecologists Committee on Obstetric Practice ACOG Committee Opinion No.468: Influenza vaccination during pregnancy. Obstet Gynecol 2010, 116:1006-1007.
36. Bednarczyk R.A., Adjaye-Gbewonyo D., Omer S.B. Safety of influenza immunization during pregnancy for the fetus and the neonate. Am J Obstet Gynecol 2012, 207:S38-S46.
37. Fell D.B., Dodds L., MacDonald N.E., Allen V.M., McNeil S. Influenza vaccination and fetal and neonatal outcomes. Expert Rev Vacc 2013, 12:1417-1430.
38. Flore A.E., Shay D.K., Broder K., Iskander J.K., Uyeki T.M., Mootrey G., et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009, 58:1-52.
39. Centers for Disease Control and Prevention (CDC) Interim results: influenza A (H1N1) 2009 monovalent vaccination coverage - United States, Octover-December 2009. MMWR Morb Mortal Wkly Rep 2010, 59:44-48.
40. Centers for Disease Control and Prevention (CDC) Influenza vaccination coverage among pregnant women: 2011-2012 influenza season, United States. MMWR Morb Mortal Wkly Rep 2012, 61:758-763.
41. Tamma P.D., Ault K.A., del Rio C., Steinhoff M.C., Halsey N.A., Omer S.B. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2009, 201:547-552.
42. Heinonen O.P., Shapiro S., Monson R.R., Hartz S.C., Rosenberg L., Slone D. Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. Int J Epidemiol 1973, 2:229-235.
43. Heinonen O.P., Slone D., Shapiro S. The collaborative perinatal project. Birth defects and drugs in pregnancy 1977, 8-14:314-321. Littleton Publishing Sciences Group, Boston, MA. D.W. Kaufman (Ed.).
44. Murray D.L., Imagawa D.T., Okada D.M., St Geme J.W. Antibody response to monovalent A/New Jersey/8/76 influenza vaccine in pregnant women. JClin Microbiol 1979, 10:184-187.
45. Sumaya C.V., Gibbs R.S. Immuniztion of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. JInfect Dis 1979, 140:141-146.
46. Deinard A.S., Ogburn P. A/NJ/8/76 influenza vaccination program: effects on maternal health and pregnancy outcome. Am J Obstet Gynecol 1981, 140:240-245.
47. Englund J.A., Mbawuike I.N., Hammill H., Holleman M.C., Baxter B.D., Glezen W.P. Maternal immuniztion with influenzaor tetanus toxoid vaccine for passive antibody protection in young infants. JInfect Dis 1993, 168:647-656.
48. Yeager D.P., Toy E.C., Baker B. Influenza vaccination in pregnancy. Am J Perinatol 1999, 16:283-286.
49. Black S.B., Shinefield H.R., France E.K., Fireman B.H., Platt S.T., Shay D. Effectiveness of influenza vaccine during pregnancy in preventing infants. Am J Perinatol 2004, 21:333-339. Vaccine Safety Datalink Workgroup.
50. Munoz F.M., Greisinger A.J., Wehmanen O.A., Mouzoon M.E., Hoyle J.C., Smith F.A., et al. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2005, 192:1098-1106.
51. France E.K., Smith-Ray R., McClure D., Hambidge S., Xu S., Yamasaki K., et al. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness among infants. Arch Pediatr Adolesc Med 2006, 160:1277-1283.
52. Zaman K., Roy E., Arifeen S.E., Rahman M., Raqib R., Wilson E., et al. Effectiveness of maternal influenza immunization in mothers and infants. NEngl J Med 2008, 359:1555-1564.
53. Nordin J.D., Kharbanda E.O., Benitez G.V., Nichol K., Lipkind H., Naleway A., et al. Maternal safety of trivalent inactivated influenza vaccine in pregnant women. Obstet Gynecol 2013, 121:519-525.
54. Kharbanda E.O., Vazquez-Benitez G., Lipkind H., Naleway A., Lee G., Nordin J.D. Vaccine Safety Datalink Team. Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events. Obstet Gynecol 2013, 122:659-667.
55. Nordin J.D., Kharbanda E.O., Vazquez Benitez G., Lipkind H., Vellozzi C., Destefano F. Maternal influenza vaccine and risks for preterm or small for gestational age birth. JPediatr 2014, 164:1051-1057. Vaccine Safety Datalink.
56. Moro P.L., Tepper N.K., Grohskopf N.K., Vellozzi C., Broder K. Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy. Expert Rev Vacc 2012, 11:911-921.
57. Pasternak B., Svanstrom H., Molgaard-Nielsen D., Krause T.G., Emborg H.D., Melbye M., et al. Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark. BMJ 2012, 344. e2794.
58. Fell D.B., Sptague A.E., Liu N., Yasseen A.S., Wen S.W., Smith G., et al. H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes. Am J Public Health 2012, 102:e33-e40.
59. Oppermann M., Fritzsche J., Wever-Schoendorfer C., Keller-Stanislawski B., Allignol A., Meister R., et al. A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine 2012, 30:4445-4452.
60. Travares F., Nazareth I., Monegal J.S., Kolte I., Verstraeten T., Bauchau V. Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study. Vaccine 2011, 29:6358-6365.
61. Lim S.H., Lee J.H., Kim B.C., Jung S.U., Park Y.B., Lee C.S. Adverse reaction of influenza A (H1N1) 2009 virus vaccination in pregnant women and its effect on newborns. Vaccine 2010, 28:7455-7456.
62. Omon E., Damase-Michel C., Hurault-Delarue C., Lacroix I., Montastruc J.L., Oustric S., et al. Non-adjuvanted 2009 influenza A (H1N1)v vaccine in pregnant women: the results of a French prospective descriptive study. Vaccine 2011, 29:9649-9654.
63. Mackenzie I.S., Macdonald T.M., Shakir S., Dryburgh M., Mantay B.J., McDonnell P., et al. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. Br J Clin Pharmacol 2011, 801-811.
64. Moro P.L., Museru O.I., Broder K., Cragan J., Zheteyeva Y., Tepper N., et al. Safety of influenza A (H1N1) 2009 live attenuated monovalent vaccine in pregnant women. Obstet Gynecol 2013, 122:1271-1278.
65. Chamber T.M., Johnson D., Xu R., Luo Y., Louik C., Mitchell A.A., et al. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants. Vaccine 2013, 31:5026-5032.
66. Louik C., Ahrens K., Kerr S., Pyo J., Chambers C., Jones K.L., et al. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: exposure prevalence, preterm delivery, and specific birth defects. Vaccine 2013, 31:5033-5040.
67. Conlin A.M., Bukowinski A.T., Sevick C.J., DeScisciolo C., Crum-Cianflone N.F. Safety of the pandemic H1N1 influenza vaccine among pregnant U.S. military women and their newborns. Obstet Gynecol 2013, 121:511-518.
68. Pasternak B., Svanström H., Mølgaard-Nielsen D., Krause T.G., Emborg H.D., Melbye M., et al. Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy. JAm Med Assoc 2012, 308:165-174.
69. Horiya M., Hisano M., Iwasaki Y., Hanaoka M., Watanabe N., Ito Y., et al. Efficacy of double vaccination with the 2009 panemic influenza A (H1N1) vaccine diruing pregnancy. Obstet Gynecol 2011, 118:887-894.
70. Ohfuji S., Fukushima W., Deguchi M., Kawabata K., Yoshida H., Hatayama H., et al. Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine among pregnant women: lowered antibody response by prior seasonal vaccination. JInfect Dis 2011, 203:1301-1308.
71. Lin S.Y., Wu E.T., Lin C.H., Shyu M.K., Lee C.N. The safety and immunogenicity of trivalent inactivated influenza vaccination: a study of maternal cord blood pairs in Taiwan. PLoS One 2013, 8. e62983.
72. Fisher B.M., Van Bockern J., Hart J., Lynch A.M., Winn V.D., Gibbs R.S., et al. Pandemic influenza A H1N1 2009 infection versus vaccination; a cohort study comparing immune responses in pregnancy. PLoS One 2012, 7. e33048.
73. Abzug M.J., Nachman S.A., Muresan P., Handelsman E., Watts D.H., Fenton T., et al. Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women. Clin Infect Dis 2013, 56:1488-1497.
74. Fukushima W., Ohfuji S., Deguchi M., Kawabata K., Hatayama H., Yoshida H., et al. Effectiveness of influenza A (H1N1) 2009 monovalent vaccine among Japanese pregnant women: a prospective observational study assessing antibody efficacy. Vaccine 2012, 30:7630-7636.
75. Hardelid P., Fleming D.M., McMenamin J., Andrews N., Robertson C., SebastianPillai P., et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveill 2011, 16. pii=19763.
76. Wu J., Xu F., Lu L., Lu M., Miao L., Gao T., et al. Safety and effectiveness of a 2009 H1N1 vaccine in Geijing. NEngl J Med 2010, 363:2416-2423.
77. Thompson M.G., Sokolow L.Z., Almendares O., Openo K., Farley M.M., Meek J., et al. Effectiveness of nonadjuvanted monovalent influenza A(H1N1)pdm09 vaccines for preventing reverse transcription polymerase chain reaction-confirmed pandemic influenza hospitalizations: case-control study of children and adults at 10 US influenza surveillance network sites. Clin Infect Dis 2013, 57:1587-1592.
78. Quach C., Piche-Walker L., Platt R., Moor D. Risk factors associated with severe influenza infections in childhood: implication for vaccine strategy. Pediatrics 2003, 112:e197-201.
79. Neuzil K.M., Mellen B.G., Wright P.F., Mitchel E.F., Griffin M.R. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. NEngl J Med 2000, 342:225-231.
80. Murphy T.V., Slade B.A., Broder K.R., Kretsinger K., Tiwari R., Joyce P.M., et al. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008, 57:1-51.
81. Reuman P.D., Ayoub E.M., Small P.A. Effect of passive maternal antibody on influenza illness in children; a prospective study of influenza A in mother-infant pairs. Pediatr Infect Dis J 1987, 6:398-403.
82. Puleston R.L., Bugg G., Hoschler K., Konje J., Thornton J., Stephenson I., et al. Observation study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy. Health Technol Assess 2010, 14:1-82.
83. Zuccotti G., Pogliani L., Pariani E., Amendola A., Zanetti A. Transplacental antibody transfer following maternal immunization with a pandemic 2009 influenza A(H1N1) MF59-adjuvanted vaccine. JAm Med Assoc 2010, 304:2360-2361.
84. Benowitz I., Esposito D.B., Gracey K.D., Shapiro E.D., Vazquez M. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis 2010, 51:1355-1361.
85. Poehling K.A., Szilagyi P.G., Staat M.A., Snively B.M., Payne D.C., Bridges C.B., et al. Impact of maternal immunization on influenza hospitalizations in infants. Am J Obstet Gynecol 2011, 204:S141-S148.
86. Eick A.A., Uyeki T.M., Klimov A., Hall H., Reid R., Santosham M., et al. Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med 2011, 165:104-111.
87. Skowronski D.M., De Serres G. Is routine influenza immuniztion warranted in early pregnancy?. Vaccine 2009, 27:4754-4770.
88. Centers for Disease Control and Prevention (CDC) Prevention and control of influenza recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention. MMWR Recomm Rep 1995, 44:1-22.
89. Centers for Disease Control and Prevention (CDC) Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997, 46:1-25.
90. Bridges C.B., Harper S.A., Fukuda K., Uyeki T.M., Cox N.J., Singleton J.A. Advisory committee on immunization practices. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2003, 52:1-34.
91. Harper S.A., Fukud K., Uyeki T.M., Cox N.J., Bridges C.B. Centers for disease control and prevention (CDC) advisory committee on immunization practices (ACIP). 2004. Prevention and control of influenza; recommendations of the advisory committee on immuniztion practices (ACIP). MMWR Recomm Rep 2004, 53:1-40.
92. ACOG Committee on obstetric Practice ACOG committee opinion number 305, November 2004. Influenza vaccination and treatment during pregnancy. Obstet Gynecol 2004, 104:1125-1126.